Literature DB >> 19382105

Sample size for two-stage studies with maintenance therapy.

Wentao Feng1, Abdus S Wahed.   

Abstract

An adaptive treatment strategy (ATS) is defined as a sequence of treatments and intermediate responses. ATS' arise when chronic diseases such as cancer and depression are treated over time with various treatment alternatives depending on intermediate responses to earlier treatments. Clinical trials are often designed to compare ATSs based on appropriate designs such as sequential randomization designs. Although recent literature provides statistical methods for analyzing data from such trials, very few articles have focused on statistical power and sample size issues. This paper presents a sample size formula for comparing the survival probabilities under two treatment strategies sharing same initial, but different maintenance treatment. The formula is based on the large sample properties of inverse-probability-weighted estimator. Simulation study shows strong evidence that the proposed sample size formula guarantees desired power, regardless of the true distributions of survival times. Copyright 2009 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2009        PMID: 19382105     DOI: 10.1002/sim.3593

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  12 in total

1.  Sample size formulae for two-stage randomized trials with survival outcomes.

Authors:  Zhiguo Li; Susan A Murphy
Journal:  Biometrika       Date:  2011-07-13       Impact factor: 2.445

2.  Dynamic treatment regimes for managing chronic health conditions: a statistical perspective.

Authors:  Bibhas Chakraborty
Journal:  Am J Public Health       Date:  2010-11-18       Impact factor: 9.308

3.  Efficient design and inference for multistage randomized trials of individualized treatment policies.

Authors:  Ree Dawson; Philip W Lavori
Journal:  Biostatistics       Date:  2011-07-16       Impact factor: 5.899

4.  Dynamic Treatment Regimes.

Authors:  Bibhas Chakraborty; Susan A Murphy
Journal:  Annu Rev Stat Appl       Date:  2014       Impact factor: 5.810

5.  Sequential, Multiple Assignment, Randomized Trial Designs in Immuno-oncology Research.

Authors:  Kelley M Kidwell; Michael A Postow; Katherine S Panageas
Journal:  Clin Cancer Res       Date:  2017-08-23       Impact factor: 12.531

6.  SMART Design Issues and the Consideration of Opposing Outcomes: Discussion of "Evaluation of Viable Dynamic Treatment Regimes in a Sequentially Randomized Trial of Advanced Prostate Cancer" by by Wang, Rotnitzky, Lin, Millikan, and Thall.

Authors:  Daniel Almirall; Daniel J Lizotte; Susan A Murphy
Journal:  J Am Stat Assoc       Date:  2012-04-27       Impact factor: 5.033

7.  Comparison of adaptive treatment strategies based on longitudinal outcomes in sequential multiple assignment randomized trials.

Authors:  Zhiguo Li
Journal:  Stat Med       Date:  2016-09-19       Impact factor: 2.373

8.  A global logrank test for adaptive treatment strategies based on observational studies.

Authors:  Zhiguo Li; Marcia Valenstein; Paul Pfeiffer; Dara Ganoczy
Journal:  Stat Med       Date:  2013-09-20       Impact factor: 2.373

9.  Design of sequentially randomized trials for testing adaptive treatment strategies.

Authors:  Semhar B Ogbagaber; Jordan Karp; Abdus S Wahed
Journal:  Stat Med       Date:  2015-09-27       Impact factor: 2.373

10.  SMART designs in cancer research: Past, present, and future.

Authors:  Kelley M Kidwell
Journal:  Clin Trials       Date:  2014-04-14       Impact factor: 2.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.